The modulating effects of propofol and its lipid carrier on canine neutrophil functions.
Propofol (2,6-diisopropylphenol), being used as an intravenous sedative and anesthetic agent, influences not only upon nervous system but also for host inflammatory response through modulating neutrophil functions. This study is designed to evaluate the modulating effects of propofol and its lipid carrier administration at clinically relevant rate on canine neutrophil functions. Clinically healthy beagle dogs were received propofol (8.8 mg/kg) from cephalic vein and maintained with propofol dropping infusion (26.4 mg/kg/hr). Blood samples were collected from the dogs before infusion and 30 min after the start of propofol administration, and neutrophil functions were evaluated. The dogs were also administered lipid carrier, and neutrophil functions were evaluated in the same manner as propofol administration. Peripheral white blood cell and neutrophil counts decreased after the propofol or lipid carrier administration. The administration of propofol or lipid carrier significantly reduced neutrophil adherence ability. The superoxide production of neutrophils was measured by luminol-dependent chemiluminescence response using with opsonized zymosan. Peak height of neutrophil chemiluminescence curve was reduced by propofol and lipid carrier administration, on the contrary, peak time of neutrophil chemiluminescence curve was delayed. Administration of propofol or lipid carrier also reduced neutrophil adherence ability to nylon fibers. In the present study, we showed the modulating effects of propofol and its lipid carrier on canine neutrophil functions. However, there was no significant difference in the modulating effects between propofol group and lipid carrier group. Therefore, the modulating effects observed here were deeply concerned in lipid carrier administration.
Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, 3-18-8, Ueda, Morioka, Iwate 020-8550, Japan.
Reeko
R
Sato
Takuma
T
Aoki
Saori
S
Kobayashi
Naohiro
N
Uchida
Shunsuke
S
Simamura
Masahiro
M
Yamasaki
D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects; D004285:Dogs; D004337:Drug Carriers / Q000494:pharmacology; D005260:Female; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000494:pharmacology*; D007958:Leukocyte Count / Q000662:veterinary; D008055:Lipids / Q000494:pharmacology; D008297:Male; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D015742:Propofol / Q000008:administration & dosage / Q000494:pharmacology*; D013481:Superoxides / Q000378:metabolism
D018686:Anesthetics, Intravenous; D004337:Drug Carriers; D006993:Hypnotics and Sedatives; D008055:Lipids; D013481:Superoxides; D015742:Propofol
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jan;376(5):331-9
18064439
Anesthesiology. 2008 Sep;109(3):426-35
18719440
Vet Immunol Immunopathol. 2009 Aug 15;130(3-4):187-96
19297030
Br J Anaesth. 2011 Apr;106(4):590-9
21307008
J Vet Med Sci. 2012 May;74(5):663-5
22198056
Cytometry A. 2004 Jan;57(1):53-62
14699606
Anesth Analg. 1998 Sep;87(3):695-700
9728856
Can J Vet Res. 1993 Oct;57(4):255-61
7903594
J Immunol. 2013 Jun 15;190(12):6511-9
23670191
Anesth Analg. 2002 Oct;95(4):952-5, table of contents
12351275
Anesthesiology. 2004 Oct;101(4):912-7
15448524
Anesthesiology. 2003 Feb;98(2):329-36
12552189
Br J Anaesth. 2000 Sep;85(3):424-30
11103185
Anesth Analg. 1998 Jun;86(6):1289-93
9620522
Anesthesiology. 2003 Sep;99(3):603-13
12960544
Pharmacotherapy. 2005 May;25(5 Pt 2):28S-33S
15899746
Immunology. 1985 Aug;55(4):629-38
2991127